InstalabLoading...
InstalabLoading...
Your AHI (Apnea-Hypopnea Index) is the single most important number to come out of a sleep study. It tells you how many times per hour your breathing partially or fully stops while you sleep. A higher number means more disruption, more drops in oxygen, and more strain on your heart and brain overnight. If you snore, wake up tired despite enough hours in bed, or have been told you stop breathing at night, this is the test that puts a number on the problem.
The number itself is straightforward. During a sleep study, sensors track every time your airflow drops significantly. A complete pause in breathing lasting more than 10 seconds counts as an apnea. A partial reduction, where airflow drops by at least 30% and your blood oxygen dips or your brain briefly wakes you, counts as a hypopnea. Add them all up, divide by hours of sleep, and you get your AHI.
What makes this number so clinically useful is that it maps directly onto severity categories that guide treatment decisions and predict health risks, especially cardiovascular risks. The higher your AHI, the more urgently you and your clinician need to act.
Your AHI falls into one of four categories. Several factors influence your result, including your weight, sleep position, alcohol use, medications, and even fluid balance. Because of this, your AHI can vary from night to night, so think of it as a snapshot rather than a fixed number.
| AHI Range | Severity | What It Means for You |
|---|---|---|
| Fewer than 5 events per hour | Normal | Your breathing during sleep is not significantly disrupted |
| 5 to 14.9 events per hour | Mild | Your breathing is interrupted several times an hour; treatment is recommended if you have symptoms like daytime sleepiness or conditions like high blood pressure |
| 15 to 29.9 events per hour | Moderate | Your breathing is frequently disrupted; treatment is recommended regardless of symptoms |
| 30 or more events per hour | Severe | Your breathing stops or weakens at least once every two minutes; treatment is strongly recommended given significant cardiovascular risk |
What this means for you: if your AHI is 15 or higher, the evidence supports starting treatment. If your AHI falls between 5 and 14, treatment is still recommended when you have symptoms like excessive daytime sleepiness, trouble concentrating, or mood changes, or if you have cardiovascular conditions such as hypertension, heart disease, or a history of stroke.
The most common reason to measure your AHI is unexplained daytime sleepiness. But the list of reasons to consider a sleep study is broader than most people realize. If you experience unrefreshing sleep, fatigue that does not improve with more time in bed, frequent nighttime urination, morning headaches, or nighttime acid reflux, a sleep study may provide answers.
Certain physical traits substantially raise your odds of having obstructive sleep apnea. Obesity is the best-documented risk factor: OSA is present in more than 40% of people with a BMI above 30 and 60% of those with metabolic syndrome. Men are 2 to 4 times more likely to have OSA than women, though risk rises in women after menopause. A neck circumference above 17 inches in men or 16 inches in women is another red flag, as are structural features of the jaw and throat like a receding chin or enlarged tonsils.
If you have cardiovascular disease, screening is especially important. The American Heart Association notes that OSA prevalence runs between 40% and 80% in people with hypertension, heart failure, coronary artery disease, atrial fibrillation, and stroke. Specific situations where screening is recommended include poorly controlled high blood pressure, pulmonary hypertension, and recurrent atrial fibrillation after treatment.
If you are planning surgery, it is worth knowing your AHI beforehand. Undiagnosed OSA raises the risk of complications during and after anesthesia. The STOP-BANG questionnaire was developed specifically for this preoperative screening purpose.
The relationship between your AHI and your heart health follows a clear dose-response pattern. The more events per hour, the higher your risk. This is not a vague association; it has been quantified across large populations.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Over 36,000 adults in a pooled analysis | Cardiovascular disease risk across OSA severity levels | People with mild OSA had about 13% higher risk; moderate OSA about 16% higher; severe OSA about 41% higher |
| Over 36,000 adults in a pooled analysis | Risk per 10-unit increase in AHI | Every additional 10 events per hour was linked to a 9% increase in cardiovascular disease risk |
| Large cohort studies of men and women | Stroke risk with AHI of 20 or higher | Men had roughly 4 times the risk of stroke; women had roughly 2 times the risk |
| Sleep Heart Health Study participants | All-cause mortality with AHI above 30 | Severe OSA was associated with 46% higher risk of death from any cause |
| Wisconsin Sleep Cohort participants | Mortality in untreated severe OSA | Untreated severe OSA was linked to roughly 3-fold higher mortality |
Sources: Zhang et al. meta-analysis (row 1, 2); Veasey and Rosen (row 3); Cowie et al. JACC review (row 4, 5).
What this means for you: a severe AHI is not just a sleep problem. It is a cardiovascular risk factor on par with conditions most people take very seriously. Untreated severe OSA has been linked to fatal cardiovascular events at roughly 3 times the rate seen in mild or moderate cases. If your AHI is above 30, treating it is one of the most impactful things you can do for your long-term health.
One nuance worth noting: your AHI does not capture everything. How much time you spend with low blood oxygen levels during sleep may be an independent predictor of cardiovascular risk. If your sleep study includes oxygen saturation data, that information adds meaningful context to your AHI alone.
Unlike a blood marker you might try to nudge with a supplement, your AHI reflects the physical dynamics of your airway during sleep. That said, several interventions have measurable effects, and the evidence behind them ranges from randomized trials to observational data.
CPAP (continuous positive airway pressure): This is the most effective treatment. CPAP works by delivering a steady stream of air through a mask, keeping your airway open throughout the night. It can reduce AHI to near-normal levels. The challenge is using it enough: adherence, defined as more than 4 hours per night on more than 70% of nights, reaches about 75%. Auto-titrating devices that adjust pressure automatically perform as well as fixed-pressure CPAP and can be more convenient. For people who struggle with standard CPAP, bilevel devices may add about 0.8 hours per night of use.
The cardiovascular payoff of CPAP depends heavily on how much you use it. In randomized trials where compliance was variable, CPAP did not significantly reduce cardiovascular events. But a meta-analysis of over 4,100 people found that using CPAP for at least 4 hours per day reduced major cardiac and cerebrovascular events by 31%. CPAP also consistently lowers blood pressure by 2 to 3 mmHg in most people and 6 to 7 mmHg in those with resistant hypertension.
Oral appliances: For mild to moderate OSA, a custom mandibular advancement device that repositions your lower jaw forward can reduce AHI by about 13.6 events per hour. That is less than CPAP (which reduces AHI by about 19.8 events per hour), but people tend to wear oral appliances about 0.7 hours more per night and are less likely to quit using them.
Weight loss: Losing 10% of your body weight can reduce your AHI by about 26%. For anyone with OSA who is overweight, this is one of the most impactful lifestyle changes available. Bariatric surgery in people with a BMI of 35 or higher reduces AHI by about 25 events per hour compared to conservative management, though more than 97% of surgical patients still have some residual OSA afterward.
Exercise: Physical activity improves OSA independently of weight loss, with benefits that increase in a dose-dependent fashion. Even without dropping pounds, regular exercise appears to reduce airway collapsibility and improve sleep quality.
Positional therapy: If your apnea is substantially worse when you sleep on your back (your supine AHI is at least double your lateral AHI), positional therapy, using devices that keep you off your back, can reduce AHI comparably to CPAP for that subset. However, long-term adherence is only about 10%.
Surgical options: For moderate to severe OSA in people who cannot tolerate CPAP, hypoglossal nerve stimulation (a small implanted device that stimulates the nerve controlling your tongue) reduces AHI by about 24.9 events per hour, with sustained effectiveness in 75% of recipients at five years. This option requires a BMI of 32 or below and an AHI between 20 and 65. Maxillomandibular advancement surgery, which physically repositions the jaw, is the most effective surgical option, reducing AHI by roughly 45 to 48 events per hour, and is best suited for non-obese people with structural jaw or facial features contributing to their obstruction.